Fixed Income Listed Derivatives in Europe: Incumbents Face New Threats

Create a vendor selection project
Click to express your interest in this report
Indication of coverage against your requirements
A subscription is required to activate this feature. Contact us for more info.
Celent have reviewed this profile and believe it to be accurate.
We are waiting for the vendor to publish their solution profile. Contact us or request the RFX.
Projects allow you to export Registered Vendor details and survey responses for analysis outside of Marsh CND. Please refer to the Marsh CND User Guide for detailed instructions.
Download Registered Vendor Survey responses as PDF
Contact vendor directly with specific questions (ie. pricing, capacity, etc)
11 January 2013


Regulatory uncertainty and the evolving market structure are providing a unique opportunity for exchanges that have not yet operated an interest rate futures or options market in Europe.

In the report Fixed Income Listed Derivatives in Europe: Incumbents Face New Threats, Celent analyzes the entry of new players into the listed interest rate derivatives market. Currently, the leading European exchanges are NYSE Liffe and Eurex. With the introduction of the European Market Infrastructure Regulation (EMIR), the current balance between listed and OTC derivatives is going to be affected, and the clear line between the two will blur. Besides EMIR, Basel III and Capital Requirements Directive implementations in Europe around capital requirements are expected to push some of the OTC flow into listed derivatives.

Changes in the market structure mean that the OTC derivatives trades that currently occur in interest rate swaps (IRS) will be electronically directed in the future to: 1) a request for quote (RFQ) IRS trading venue, and executed bilaterally when the product is extremely customized; 2) an RFQ IRS trading venue, and cleared when the product can be standardized by the sell side; or 3) to an order book IRS trading venue, and cleared when the product is easily standardized.

"Providers are trying to maximize their competitive advantage through their OTC derivatives clearing strategy,” says Anshuman Jaswal, PhD, Senior Analyst with Celent’s Securities & Investments Group and coauthor of the report. “Simultaneously, the new regulatory framework is going to involve the use of very large amounts of collateral, and trading firms are going to struggle to meet their collateral management needs in the next few years. The result will be leading exchanges working on their collateral management and cross-asset netting procedures.”

"Regulations have provided a window of opportunity for entrants in the listed fixed income derivatives market to challenge the leading exchanges," adds Joséphine de Chazournes, Senior Analyst with Celent’s Securities & Investments Group and coauthor of the report. “We are looking forward to seeing if the new competitors will be able to move entrenched liquidity.”

In this report, Celent provides insight into the potential evolution of the fixed income derivatives market in Europe. It provides an overview of current status, discusses the new initiatives that have already been announced, and finally provides potential scenarios of new developments in this market for the next few years.

This 28-page report contains seven figures and three tables.